dsm-firmenich
We are dsm-firmenich – innovators in nutrition, health, and beauty. We bring progress to life by combining the essential, the desirable, and the sustainable. From our master perfumers and flavorists to our expert nutritionists and scientists, our trailblazing teams work closely with customers, supporting their ambitions with 150+ years of R&D expertise. With a passionate and talented team of …
Profile
- Industry
- Cosmetics, Feed, Food ingredients, Industrial chemistry, Waste & circular economy
- Topics
- Animal feed & feed additives, Enzymes & biocatalysis, Vitamins, carotenoids & nutraceutical actives, Yeast, fermentation & food ingredients
- Role
- Producer — “…scope: Global development, manufacturing, and integration of nutrients, flavors, and fragrances to meet growin…”
- Why it is bioeconomy
- dsm-firmenich is a global science-based company providing animal nutrition solutions, including methane-reducing feed additives, vitamins, and enzymes, though it is currently in the process of divesting its Animal Nutrition & Health business.
Bio-solutions it supplies 1
Verified product links: vitamin C production process → FI04; EverSweet → FI02;
What they offer
Products: Alpaflor; Parsol; LifesDHA; Vitamin D3; Vitamin B12; PENTAVITIN®; REGU®-AGE PF; Argan Oil; ERYTHRULOSE; VALVANCE®_Look_100
Certifications: ISO 9001; FSSC 22000; GMP; Halal; Kosher; ECOCERT; COSMOS; NATRUE
Sites 4
- Netherlands Vitamins and food supplements Large Scale
- India Plant-based alternatives Mid Scale
- Netherlands, Large Scale, Vitamins and food supplements
- India, Mid Scale, Plant-based alternatives
Production, R&D and other sites from the company's website and automated research; street addresses omitted.
- Applications
- Beauty Care · Health Nutrition · Food and Beverage · Pet Nutrition · Biomedical Solutions
- Certifications (website)
- ISO 9001 · FSSC 22000 · GMP · Halal · Kosher · ECOCERT · COSMOS · NATRUE
- Customers & partners
- dsm-firmenich · Nestlé · Coca-Cola · Haleon
- Products (website)
- Alpaflor — A brand offering various botanical ingredients and actives for personal care. · Parsol — A range of UV filters for sun protection products. · LifesDHA — DHA oil for maternal and infant nutrition. · Vitamin D3 — Vitamin D supplement for various health benefits. · Vitamin B12 — Nutritional supplement for energy and health. · ALPAFLOR® — Bioactive ingredients extracted from resilient alpine flowers. · PENTAVITIN® — Natural moisturizing skincare ingredient providing powerful hydration. · REGU®-AGE PF · Argan Oil — An ingredient with ECOCERT, COSMOS and NATRUE organic certification, enhances natural shine and provides intensive care for dry or brittle hair. · ERYTHRULOSE — A skin-care ingredient produced by the fermentation of corn, promoting a natural, even tan. · VALVANCE®_Look_100 — Modifier with a 100% natural classification by NATRUE. · PARSOL® TX — An inorganic UV filter providing significant UVA protection.
- R&D facilities
- Netherlands · USA · Switzerland
Read from the company's own website: about · products · production · quality · rnd · leadership · contact · sustainability
Subsidiaries: Firmenich International SA · DSM Nutritional Products AG · DSM Food Specialties B.V. · Firmenich SA · DSM Nutritional Products Europe AG · DSM Finance B.V.
Business model · ingredients
dsm-firmenich is a leading nutrition, health, and beauty company that operates through three primary business units: Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care. It sells a wide range of specialty ingredients, customized solutions, and innovative products to business-to-business customers globally, focusing on co-creation and science-driven innovation. The company earns revenue primarily through the sale of these performance ingredients and solutions, often priced based on the value created for customers through their functional, nutritional, and sustainable benefits.
| 2025 In 2025, dsm-firmenich reported net sales of €9,034 million for its continuing operations. “Net sales 9,034 9,054 2,102 26 9,034” | annualreport.dsm-firmenich.com weak (company, news, market research, other) |
| 2025 The Adjusted EBITDA margin for continuing operations in 2025 was 19.6%. “Adjusted EBITDA margin (in %)” | annualreport.dsm-firmenich.com weak (company, news, market research, other) |
| 2025 The company invests approximately 7% of its sales in R&D. “~7% R&D spend of sales €9bn Sales” | www.dsm-firmenich.com weak (company, news, market research, other) |
| 2025 The company holds an expanding portfolio of more than 11,000 patents. “Our expanding portfolio of more than 11,000 patents, together with substantial and ongoing investments in R&D and innovation, empowers our Science & Research team to deliver transformational solutions that the world …” | www.dsm-firmenich.com weak (company, news, market research, other) |
| 2023 dsm-firmenich was formed in 2023 through the merger of DSM N.V. and Firmenich International SA. “dsm-firmenich came into being in May 2023 through the merger of Netherlands-based DSM N.V. and Swiss-based Firmenich International SA.” | www.dsm-firmenich.com weak (company, news, market research, other) |
| Vitamin C 2025 The company's low-carbon vitamin C production process at its Dalry facility replaced traditional coal-powered manufacturing methods, resulting in a 49% lower carbon footprint. “The headline result was that Dalry's vitamin C achieved a 49% lower carbon footprint compared to mainstream vitamin C alternatives, as confirmed by a third-party verified LCA aligned with ISO 14040/44 standards.” | dev.dsm-firmenich.com weak (company, news, market research, other) |
| EverSweet stevia sweetener 2025 The EverSweet stevia sweetener, created through advanced fermentation, replaced conventional Stevia Reb A production with a 49% lower carbon footprint. “Created through advanced fermentation methods, the carbon footprint of EverSweet® is 49% lower than the equivalent amount of Stevia Reb A, offering the same sweetness.” | www.dsm-firmenich.com weak (company, news, market research, other) |
Status
- 2026-05 Latest status: The company announced the divestment of its Animal Nutrition & Health business to CVC Capital Partners in February 2026 and established a dual listing on the SIX Swiss Exchange in May 2026. ↗ ↗ ↗
Recent news 5
Found by automated search; summaries are machine-written in English. The headline names the company or the summary is about it — check the source before relying on it.
- 2026-10-01 DSM-Firmenich: Einblick in die Schweizer Duftschmiede bilanz.chDSM-Firmenich is being retooled after a failed megafusion, with CEO Dimitri de Vreeze driving a rapid, radical restructuring that trims away divisions and concentrates on high-margin fragrance and flavor ingredients, particularly strong operations in Satigny and Kaiseraugst. The …
- 2026-09-27 DSM-Firmenich Shifts Strategy: 230 Global Jobs Cut to Combat Chinese Market Pressure imago.com.arDSM-Firmenich is cutting 230 global jobs, focusing on Swiss sites Sisseln and Kaiseraugst, to cut costs and stay competitive amid aggressive Chinese competition in fragrances, flavors, and ingredients. The move signals broader European industry consolidation and potential …
- 2026-09-23 DSM-Firmenich im Hoch: Givaudan im Visier bilanz.chDSM-Firmenich is aiming to climb to the top of the perfume industry by leveraging its 1,800-strong fragrance library and heavy emphasis on creative “Nez” perfumers, seeking to rival industry leader Givaudan after its Firmenich acquisition.
- 2026-09-14 dsm-firmenich partners with Boltz on AI for ingredient discovery our-company.dsm-firmenich.comdsm-firmenich is partnering with Boltz PBC to accelerate ingredient discovery using advanced AI models, integrating Boltz’s biomolecular modeling with its extensive sensory data to design new scent and flavor molecules. The collaboration includes full access to Boltz tools and …
- 2026-07-30 dsm-firmenich reports H1 2026 results our-company.dsm-firmenich.comdsm-firmenich delivered solid H1 2026 momentum with 5% like-for-like sales growth (6% in Q2), an improving adjusted EBITDA margin, and stronger cash conversion, supporting guidance that targets ~2-4% LFL growth and around 20% EBITDA margin for 2026. The company remains on track …
Network: owners, partners, peers
Ownership & investors 6
| subsidiary | Firmenich International SA |
| subsidiary | DSM Nutritional Products AG |
| subsidiary | DSM Food Specialties B.V |
| subsidiary | Firmenich SA |
| subsidiary | DSM Nutritional Products Europe AG |
| subsidiary | DSM Finance B.V |
Partners & deals 2
| counterparty | CVC Capital Partners (for Animal Nutrition & Health divestment) …The company announced the divestment of its Animal Nutrition & Health business to CVC Capital Partners in February 2026 and established a dual listing on the SIX Swiss Exchange in May 2026.… |
| joint venture | Bovaer …tained ownership of the methane-reducing feed additive Bovaer and the algae-based omega-3 joint venture Veramaris. The company employs approximately 21,000 people and reported over €9 billion i… |
Similar companies
AVEVE Biochem · Impextraco · Vilofoss Group · Novonesis · METEX NØØVISTAGO · c-LEcta GmbH · Groupe Roullier · Biostrong
Company facts
Registry identifiers
- ISIN: CH1216478797
- ISIN: CH1267772122
Funding
- Latest round: Post ipo debt · 2025-03-19 · US$ 783.8 M
- Total raised: US$ 2.7 B
From automated research (company websites, filings, a commercial company index); not checked by hand. Registry identifiers: confirm in the official registry.
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member